DRDGOLD Ltd
XMUN:DUB1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DRDGOLD Ltd
XMUN:DUB1
|
ZA |
|
D
|
Danaher Corp
XMUN:DAP
|
US |
|
V
|
Vertex Pharmaceuticals Inc
BMV:VRTX
|
US |
|
I
|
IPG Photonics Corp
F:IPF
|
US |
|
B
|
BRP Inc
F:B15A
|
CA |
|
N
|
Novartis AG
SWB:NOTA
|
CH |
|
C
|
Citigroup Inc
LSE:0R01
|
US |
|
Galapagos NV
F:GXE
|
BE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DUB1's stock price target?
Not Available
DUB1 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for DRDGOLD Ltd?
Projected CAGR
30%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 30%.
What is the Gross Profit forecast for DRDGOLD Ltd?
Projected CAGR
42%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 42%.
What is the Operating Income forecast for DRDGOLD Ltd?
Projected CAGR
47%
Over the last 13 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 3 years is 47%.
What is the Pre-Tax Income forecast for DRDGOLD Ltd?
Projected CAGR
53%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 21%. The projected CAGR for the next 3 years is 53%.
What is the Net Income forecast for DRDGOLD Ltd?
Projected CAGR
54%
Over the last 13 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 3 years is 54%.
